Skip to main content

Table 1 Patient characteristics

From: Comparison of deep or moderate neuromuscular blockade for thoracoscopic lobectomy: a randomized controlled trial

 

Moderate group (n = 29)

Deep group (n = 29)

Age, mean(SD), y

56.86(8.25)

56.59(9.70)

Weight, mean(SD), kg

59.66(8.28)

62.59(7.98)

Height, mean(SD), m

1.64(0.08)

1.65(0.07)

BMI, mean(SD)

22.56(2.82)

22.90(2.24)

Women, No. (%)

17(58.62)

16(55.17)

Left lobectomy, No. (%)

11(37.93)

12(41.38)

Central lung cancer, No. (%)

13(44.83)

13(44.83)

TNM stage, No. (%)

 Ia

25(86.21)

22(75.86)

 Ib

0(0)

2(6.90)

 IIa

4(13.79)

4(13.79)

 IIb

0(0)

1(3.45)

tumor size, No. (%), cm

 <2

19(65.52)

19(65.52)

 ≥2

10(34.48)

10(34.48)

lymph node retrieved number, No. (%)

 <10

12(41.38)

11(37.93)

 ≥10

17(58.62)

18(62.07)

lymph node metastasis, No. (%)

4(13.79)

5(17.24)

  1. SD standard deviation. BMI body mass index